Last edition
News about "Steve Potts"
Breakthru Medicine Raises USD 60 Million Series A to Advance Cancer Drugs
Founded by biotech veterans Steve Potts, Mark Mulvihill and Brian Barnett, Breakthru Medicine has raised USD 60 million in Series A funding to advance its stealth oncology pipeline, including molecular glues, small molecules and novel ADC payloads.
Steve Potts | 02/02/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members